Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The genetics of pro-arrhythmic adverse drug reactions.

British journal of clinical pharmacology - 1 Apr 2014

Petropoulou Evmorfia, Jamshidi Yalda, Behr Elijah R

Abstract excerpt

Ventricular arrhythmia induced by drugs (pro-arrythmia) is an uncommon event, whose occurrence is unpredictable but potentially fatal. The ability of a variety of medications to induce these arrhythmias is a significant problem facing the pharmaceutical industry. Genetic variants have been shown to play a role in adverse events and are also known to influence an individual's optimal drug dose. This review...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Arrhythmia Agents
Share to Arrhythmias, Cardiac
Share to Genetic Variation

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genome-Wide Association Study

Share to Inactivation, Metabolic

Share to Long QT Syndrome

Share to Risk Factors

Share to Torsades de Pointes

Source

Open in PubMed Open full text

Identifiers

PMID: 23834499
DOI: 10.1111/bcp.12208
PMCID: PMC3971979

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The genetics of pro-arrhythmic adverse drug reactions.PMID 23834499Read ↗

Pharmacogenetics and drug-induced arrhythmiasSemantic proximity Read ↗

Drug-induced arrhythmia: pharmacogenomic prescribing?Semantic proximity Read ↗

Pharmacogenetics of Drug-Induced QT Interval Prolongation: An Update.Semantic proximity Read ↗

Pharmacogenetics of Adverse Drug Reactions.Semantic proximity Read ↗

[Pharmacogenetic aspects of antiarrhythmic drug therapy].Semantic proximity Read ↗

Role of Pharmacogenetics in Adverse Drug Reactions: An Update towards Personalized MedicineSemantic proximity Read ↗

Pharmacogenomics and Acquired Long QT SyndromeSemantic proximity Read ↗

Drug‐ and non‐drug‐associated QT interval prolongationSemantic proximity Read ↗

Drug-induced proarrhythmia: risk factors and electrophysiological mechanisms.Semantic proximity Read ↗

Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges.Semantic proximity Read ↗

Pharmacogenetics and adverse drug reactions.Semantic proximity Read ↗

Monogenic Syndromes as a Cause of Adverse Drug Reactions in the Russian PopulationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.